National conference covering issues pertinent to PDMPs, healthcare stakeholders, and state and federal government representatives.
Please check the box next to the following questions if the answer is 'yes'.
This meeting was attended by approximately 176 attendees and presenters, a post event survey indicated a high approval rating for the information and presentations and facilitation of the meeting.
BJA, CDC, DEA, FDA, SAMHSA, PDMPs (FL, NY, MD, MT, OH, SD), NAMSDL, Veterans Affairs, Indian Health Services,
Please enter the applicable Event Date if there is an Event associated with this TTA.
When entering an Event Date, the Time is also required.
If the TTA is targeted to a particular audience or location, please complete the questions below.
Milestones are an element, activity, work product, or key task associated with completing the TTA (e.g. kick-off meeting, collect data from stake holders, deliver initial data analysis).
Please complete the fields below, if applicable, to create a milestone for this TTA.
PDMPs had the opportunity to meet with other PDMPs and federal agencies to learn of best practices, current resources and sharing of information.
The 10th Harold Rogers Prescription Drug Monitoring Program National Meeting, held in Washington, D.C. from September 22nd through 24th, was a tremendous success. Over 200 people registered for this two and a half day national meeting sponsored by the Bureau of Justice Assistance (BJA). The meeting attendees included twenty-eight PDMP administrators and twenty-three members of their staff, representing thirty-seven states and the District of Columbia. Attendees also included seventy-two representatives of state and federal agencies, forty-five representatives of other organizations and industry, PDMP Technical Assistance and Training Center (TTAC) staff and PDMP Center of Excellence (COE) staff also attended. The first day opened with BJA Director Denise O’Donnell providing opening remarks, followed by an impactful speech from Shannon Rickett with Congressman Harold ‘Hal’ Rogers office. Commissioner Cheryl Bartlett, Massachusetts Department of Public Health, detailed the efforts to combat opioid abuse being undertaken with the Northeast Governor’s Initiative. Karin Mack, Centers for Disease Control and Prevention (CDC), presented compelling results on opioid prescribing patterns in the United States. Representatives from BJA, CDC, Drug Enforcement Administration (DEA), U.S. Food and Drug Administration (FDA), and the Substance Abuse and Mental Health Services Administration (SAMHSA) provided presentations and fielded audience questions on topics related to their respective agencies. Terence O’Leary (NY PDMPs) gave an interesting presentation about the New York State Department of Health’s I-STOP program. The day ended with three research presentations: Optimizing PDMPs to Support Law Enforcement Activity, Non-medical Use of Prescription Drugs: Policy Change, Law Enforcement Activity, and Diversion Tactics, and Controlled Substance Prescribing Trends and Risk of Drug Overdose Deaths.
Day 2 opened with a presentation by Acting Director Botticelli from the Office of National Drug Control Policy, followed by law updates from the National Alliance for Model State Drug Laws and analysis of the 2012 and 2014 state survey results by the PDMP Training and Technical Assistance Center (TTAC). There were also presentations covering innovative PDMP data uses, law enforcement outreach and training, PDMP and justice agency partnerships, interstate data sharing and health IT integration, status of data sharing with the Veterans Affairs Administration and Indian Health Services, and ending with the Florida and Montana PDMPs new initiatives.
The final day included presentations about the Prescription Behavior Surveillance System (PBSS) project and two states’ (Oregon and Massachusetts) efforts related to prescriber outreach. Following the formal presentations, a group discussion was facilitated by Dave Hopkins (KY) on a wide range of topics that impact PDMPs. The meeting concluded with remarks by BJA Deputy Director Kristen Mahoney (BJA). Copies of the presentations are posted on the TTAC website
Please respond to the Performance Metrics below. The Performance Metrics questions are based on the TTA Type indicated in the General Information section of the TTA.
Please submit a signed letter of support from your agency’s executive or other senior staff member. The letter can be emailed to or uploaded with this request. The letter should be submitted on official letterhead and include the following information:
- General information regarding the request for TTA services, i.e., the who, what, where, when, and why.
- The organizational and/or community needs specific to the request for TTA services.
- The benefits or anticipated outcomes from the receipt of TTA services.
By submitting this application to BJA NTTAC, I understand that upon approval of this application for TTA, the requestor agrees to keep BJA NTTAC informed of any circumstances that may impact the delivery of the TTA, including changes in the date of the event, event cancellation, or difficulties communicating with the assigned TTA provider.
Please call [site:phone] if you need further assistance completing this application.